Get the Stockscreener App
4.71
3.69%
-0.1806
After Hours:
4.72
0.010
+0.21%
Pulmatrix Inc stock is traded at $4.71, with a volume of 5,323.
It is down -3.69% in the last 24 hours and down -3.88% over the past month.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
See More
Previous Close:
$4.8906
Open:
$4.74
24h Volume:
5,323
Relative Volume:
0.49
Market Cap:
$17.20M
Revenue:
$11.68M
Net Income/Loss:
$-8.85M
P/E Ratio:
-1.9544
EPS:
-2.41
Net Cash Flow:
$-14.61M
1W Performance:
-2.89%
1M Performance:
-3.88%
6M Performance:
-23.04%
1Y Performance:
+0.21%
1-Day Range:
$4.61
$4.9699
1-Week Range:
$4.61
$4.9699
52-Week Range:
$4.33
$10.40
Pulmatrix Inc Stock (PULM) Company Profile
Name
Pulmatrix Inc
Sector
Industry
Phone
(888) 355-4440
Address
945 CONCORD STREET, FRAMINGHAM, MA
Compare PULM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PULM
Pulmatrix Inc
|
4.71 | 17.86M | 11.68M | -8.85M | -14.61M | -2.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Pulmatrix Inc Stock (PULM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-09-18 | Initiated | H.C. Wainwright | Buy |
Pulmatrix Inc Stock (PULM) Latest News
Will Pulmatrix Inc. (2PU) stock see valuation expansionEarnings Risk Report & Expert Approved Trade Ideas - newser.com
What market sentiment indicators show for Pulmatrix Inc. (2PU) stock2025 Sector Review & Safe Investment Capital Preservation Plans - newser.com
Is Pulmatrix Inc. (2PU) stock undervalued by metricsWeekly Trend Report & Fast Gain Stock Tips - newser.com
Trend analysis for Pulmatrix Inc. this week2025 Big Picture & Free High Return Stock Watch Alerts - newser.com
Analyzing Pulmatrix Inc. with risk reward ratio chartsRecession Risk & Safe Entry Point Identification - newser.com
Will breakout in Pulmatrix Inc. lead to full recoveryJuly 2025 Trends & Momentum Based Trading Ideas - newser.com
Using RSI to spot recovery in Pulmatrix Inc.2025 Top Decliners & Technical Confirmation Trade Alerts - newser.com
What recovery options are there for Pulmatrix Inc.July 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
Is Pulmatrix Inc. stock a smart buy before Fed meetingLayoff News & Stock Timing and Entry Methods - newser.com
Is Pulmatrix Inc. stock a good choice for value investorsEarnings Recap Summary & Fast Entry High Yield Tips - newser.com
Will Pulmatrix Inc. stock return to pre crisis levels2025 Year in Review & Long-Term Safe Return Strategies - Fundação Cultural do Pará
Why institutional investors increase stakes in Pulmatrix Inc. (2PU) stock2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
What analysts say about Pulmatrix Inc stockStock Market Trends & Exceptional Growth Investment - earlytimes.in
Will Pulmatrix Inc. stock deliver consistent dividendsJuly 2025 WrapUp & Free Long-Term Investment Growth Plans - newser.com
Will Pulmatrix Inc. stock go up soonEarnings Overview Summary & AI Forecast Swing Trade Picks - newser.com
Will Pulmatrix Inc. stock recover after recent dropFed Meeting & Fast Gain Stock Trading Tips - newser.com
How Pulmatrix Inc. (2PU) stock responds to bond marketDollar Strength & Consistent Return Investment Signals - newser.com
Is it time to cut losses on Pulmatrix Inc.July 2025 EndofMonth & Precise Entry and Exit Recommendations - newser.com
Is Pulmatrix Inc. (2PU) stock prepared for digital transition2025 Market Overview & Real-Time Buy Signal Notifications - newser.com
Is Pulmatrix Inc. stock attractive for long term wealth buildingWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - newser.com
Is Pulmatrix Inc. stock gaining market shareBond Market & Technical Pattern Alert System - newser.com
Why Pulmatrix Inc. (2PU) stock is a strong buy callGDP Growth & Real-Time Buy Zone Alerts - newser.com
Can Jumbo Bag Limited Maintain Its Share of Global Market for Its ProductPortfolio Risk Assessment & Market Trend Real-Time Reports - earlytimes.in
What drives Pulmatrix Inc stock priceInsider Trading Compliance & Exceptional Growth Investment - earlytimes.in
Pulmatrix Inc Stock (PULM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.43%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):